DCA letters
13 Oct 2009

Caution Statement on “Severe Drug Interaction Between Colchicine and P-Glycoprotein or Strong CYP3A4 Inhibitors” required to be included in the product package insert for Colchicine

Source/Author: DCA

Bil (44) dlm. BPFK/PPP/01/03 dated 13th October 2009



Source: www.bpfk.gov.my